Neila Benameur

Paris, 75013, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application.

Determination of plasma concentration of Belimumab by LC-MS/MS: Method development, validation, and clinical application.

Journal: Journal of pharmaceutical and biomedical analysis

Published: June 01, 2023

Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.

Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation.

Journal: Frontiers in immunology

Published: October 06, 2021

Acute Pancreatitis From Treatment With BRAF Inhibitors in Erdheim-Chester Disease: A Report From 2 Tertiary Referral Centers.

Acute Pancreatitis From Treatment With BRAF Inhibitors in Erdheim-Chester Disease: A Report From 2 Tertiary Referral Centers.

Journal: Pancreas

Published: December 28, 2020

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Journal: Annals of the rheumatic diseases

Published: April 09, 2020

Response to: 'Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease' by Campochiaro et al.

Response to: 'Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease' by Campochiaro et al.

Journal: Annals of the rheumatic diseases

Published: December 31, 2019

Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy.

Immune Reconstitution Syndrome After Nivolumab for Progressive Multifocal Leukoencephalopathy.

Journal: Neurology. Clinical practice

Published: August 16, 2019

Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome.

Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome.

Journal: The Journal of rheumatology

Published: July 12, 2019

Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter.

Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter.

Journal: Annals of the rheumatic diseases

Published: May 16, 2019

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.

Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.

Journal: Journal of neurology

Published: December 08, 2018

Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics.

Safety and effectiveness of transjugular renal biopsy for systemic lupus erythematosus and antiphospholipid antibody syndrome patients taking antithrombotics.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: October 05, 2018

Efficacy of infliximab in the treatment of Erdheim-Chester disease.

Efficacy of infliximab in the treatment of Erdheim-Chester disease.

Journal: Annals of the rheumatic diseases

Published: November 11, 2017

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).

Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study).

Journal: Blood

Published: July 02, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026